Skip to main navigation Skip to search Skip to main content

The cellular modifier MOAG-4/SERF drives amyloid formation through charge complementation

  • Anita Pras
  • , Bert Houben
  • , Francesco A Aprile
  • , Renée Seinstra
  • , Rodrigo Gallardo
  • , Leen Janssen
  • , Wytse Hogewerf
  • , Christian Gallrein
  • , Matthias De Vleeschouwer
  • , Alejandro Mata-Cabana
  • , Mandy Koopman
  • , Esther Stroo
  • , Minke de Vries
  • , Samantha Louise Edwards
  • , Janine Kirstein
  • , Michele Vendruscolo
  • , Salvatore Fabio Falsone
  • , Frederic Rousseau*
  • , Joost Schymkowitz*
  • , Ellen A A Nollen*
  • *Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    20 Citations (Scopus)
    196 Downloads (Pure)

    Abstract

    While aggregation-prone proteins are known to accelerate aging and cause age-related diseases, the cellular mechanisms that drive their cytotoxicity remain unresolved. The orthologous proteins MOAG-4, SERF1A, and SERF2 have recently been identified as cellular modifiers of such proteotoxicity. Using a peptide array screening approach on human amyloidogenic proteins, we found that SERF2 interacted with protein segments enriched in negatively charged and hydrophobic, aromatic amino acids. The absence of such segments, or the neutralization of the positive charge in SERF2, prevented these interactions and abolished the amyloid-promoting activity of SERF2. In protein aggregation models in the nematode worm Caenorhabditis elegans, protein aggregation and toxicity were suppressed by mutating the endogenous locus of MOAG-4 to neutralize charge. Our data indicate that MOAG-4 and SERF2 drive protein aggregation and toxicity by interactions with negatively charged segments in aggregation-prone proteins. Such charge interactions might accelerate primary nucleation of amyloid by initiating structural changes and by decreasing colloidal stability. Our study points at charge interactions between cellular modifiers and amyloidogenic proteins as potential targets for interventions to reduce age-related protein toxicity.

    Original languageEnglish
    Article numbere107568
    Number of pages18
    JournalThe EMBO Journal
    Volume40
    Issue number21
    Early online date2021
    DOIs
    Publication statusPublished - 2-Nov-2021

    Fingerprint

    Dive into the research topics of 'The cellular modifier MOAG-4/SERF drives amyloid formation through charge complementation'. Together they form a unique fingerprint.

    Cite this